关注
Rodanthi Lyraki
Rodanthi Lyraki
Institute of Molecular Biology and Biotechnology (IMBB), FORTH
在 imbb.forth.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Adrenal cortex renewal in health and disease
R Lyraki, A Schedl
Nature Reviews Endocrinology 17 (7), 421-434, 2021
612021
Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations
R Lyraki, R Megaw, T Hurd
Biochemical Society Transactions 44 (5), 1235-1244, 2016
402016
The sexually dimorphic adrenal cortex: implications for adrenal disease
R Lyraki, A Schedl
International Journal of Molecular Sciences 22 (9), 4889, 2021
362021
Osteoclast stimulation factor 1 (Ostf1) KNOCKOUT increases trabecular bone mass in mice
M Vermeren, R Lyraki, S Wani, R Airik, O Albagha, R Mort, F Hildebrandt, ...
Mammalian genome 28, 498-514, 2017
302017
Characterization of a novel RP2–OSTF1 interaction and its implication for actin remodelling
R Lyraki, M Lokaj, DC Soares, A Little, M Vermeren, JA Marsh, ...
Journal of cell science 131 (4), jcs211748, 2018
132018
Crosstalk between androgen receptor and WNT/β-catenin signaling causes sex-specific adrenocortical hyperplasia in mice
R Lyraki, A Grabek, A Tison, LC Weerasinghe Arachchige, M Peitzsch, ...
Disease Models & Mechanisms 16 (6), dmm050053, 2023
102023
From unique challenges to inspired solutions: how vector engineering makes in vivo gene therapy possible
R Lyraki
The Biochemist 45 (4), 10-14, 2023
2023
First person–Rodanthi Lyraki
R Lyraki
2023
Adrenal cortex size, homeostasis and tumorigenesis is regulated by gonadal hormones via androgen receptor/β-catenin signalling crosstalk
R Lyraki, A Grabek, A Tison, M Peitzsch, N Bechman, SA Youssef, ...
bioRxiv, 2022.06. 23.497219, 2022
2022
Molecular mechanisms underlying Retinitis pigmentosa type 2
R Lyraki
The University of Edinburgh, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–10